L'Istituto Giannina Gaslini, solitamente chiamato Ospedale Gaslini, è un Istituto di ricovero e cura a carattere scientifico di tipo pediatrico, situato a Genova, nel quartiere di Quarto, a pochi metri dal mare, fondato da Gerolamo Gaslini nel 1938.

During the past decade, Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia" are "Dravet Syndrome" (2 trials) and "Seizure Disorder" (1 trials). Many other conditions were trialed in "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia" in a lesser frequency.

Most popular intervention types in "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ZX008 (Fenfluramine Hydrochloride)" (2 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".